Vitura Health Ltd (ASX: VIT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Vitura Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $57.59 million
P/E Ratio 5.66
Dividend Yield 10.64%
Shares Outstanding 575.87 million
Earnings per share 0.017
Dividend per share 0.01
Year To Date Return -63.14%
Earnings Yield 17.66%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Vitura Health Ltd (ASX: VIT)
    Latest News

    Three rockets heading to space
    Share Gainers

    3 ASX All Ordinaries shares surging more than 10% today

    These three ASX All Ordinaries shares are trouncing the benchmark index today.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Audinate, Endeavour, IAG, and Vitura Health shares are charging higher

    These ASX shares are starting the week in a very positive fashion...

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Beach, Coles, Cronos Australia, and Woolworths shares are pushing higher

    Investors have been snapping up these shares on Tuesday...

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Cronos Australia, Pilbara Minerals, Sayona Mining, and Strike Energy are dropping

    These ASX shares have tumbled on dropped into the red on Wednesday...

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why Cronos Australia, Mesoblast, Sims, and WAM Research are dropping

    These ASX shares are missing out on the good times today...

    Read more »

    Back view of a man lifting hish hands high in front of hemp plants grown for cannabis.
    Cannabis Shares

    ASX cannabis share Cronos has soared 80% in a month. What's going on?

    This cannabis share has been on fire this month...

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Air New Zealand, Cronos, Soul Patts, and Viva Energy shares are pushing higher

    These ASX shares are having a strong day...

    Read more »

    two men in formal business clothing closely inspect a bud from a cannabis crop.
    Broker Notes

    Bell Potter slaps buy rating on this profitable, dividend-paying ASX cannabis share

    This cannabis share is smoking the market on Monday...

    Read more »

    A man in a horse head mask and suit jumps for joy on a beach.
    Earnings Results

    Guess which company just became the first ASX cannabis share to pay a dividend

    We take a a look at why this ASX cannabis share is having such a good day.

    Read more »

    A man in business suit wearing old fashioned pilot's leather headgear, goggles and scarf bounces on a pogo stick in a dry, arid environment with nothing else around except distant hills in the background.
    Cannabis Shares

    Can ASX cannabis shares ever fully recover?

    We take a look at ASX cannabis shares.

    Read more »

    A man in a horse head mask and suit jumps for joy on a beach.
    Earnings Results

    Guess which ASX cannabis share just rocketed 30%

    Cronos posts earnings today.

    Read more »

    An older farmer wearing a checkered shirt and a straw hat stands in a green field of cannabis plants growing up to waist level as he smiles while thinking about the outlook for ASX cannabis shares in FY23
    Cannabis Shares

    Green shoots or just weeds? The outlook for ASX cannabis shares in FY23

    Are cannabis stocks set to rise along with the broader industry in the new financial year?

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2023 $0.0100 100.00% Final 28 Sep 2023
    16 Sep 2022 $0.0100 100.00% Final 11 Oct 2022

    VIT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Vitura Health Ltd

    Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has three business segments namely, the Medical segment, which involves the sale of medicinal cannabis products; the Clinics segment, which involves the operation of medicinal cannabis clinics; and the Consumer segment, which involves the sale of consumer (non-medical) products in Australia and previously in Asia. The company generates the majority of its revenue from the Medical segment. Geographically the company generates the majority of its revenue from Australia.

    VIT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    15 Jul 2024 $0.09 $-0.01 -10.10% 46,718 $0.10 $0.10 $0.09
    12 Jul 2024 $0.10 $0.00 0.00% 119,951 $0.10 $0.10 $0.10
    11 Jul 2024 $0.10 $0.00 0.00% 140,841 $0.10 $0.11 $0.10
    10 Jul 2024 $0.10 $0.00 0.00% 827,929 $0.11 $0.11 $0.10
    09 Jul 2024 $0.10 $0.00 0.00% 240,343 $0.10 $0.10 $0.10
    08 Jul 2024 $0.10 $0.00 0.00% 516,223 $0.10 $0.11 $0.10
    05 Jul 2024 $0.10 $0.00 0.00% 62,216 $0.10 $0.10 $0.10
    04 Jul 2024 $0.09 $0.00 0.00% 150,284 $0.10 $0.10 $0.09
    03 Jul 2024 $0.09 $0.01 11.36% 70,398 $0.10 $0.10 $0.09
    02 Jul 2024 $0.09 $0.00 0.00% 631,525 $0.10 $0.10 $0.09
    01 Jul 2024 $0.09 $0.01 11.63% 632,243 $0.10 $0.10 $0.09
    28 Jun 2024 $0.09 $0.00 0.00% 765,114 $0.08 $0.09 $0.08
    27 Jun 2024 $0.08 $-0.01 -10.87% 730,672 $0.10 $0.10 $0.08
    26 Jun 2024 $0.09 $0.01 11.63% 1,592,324 $0.09 $0.09 $0.08
    25 Jun 2024 $0.09 $0.00 0.00% 284,192 $0.09 $0.09 $0.09
    24 Jun 2024 $0.09 $0.00 0.00% 327,013 $0.10 $0.10 $0.09
    21 Jun 2024 $0.09 $0.00 0.00% 59,545 $0.10 $0.10 $0.09
    20 Jun 2024 $0.10 $0.00 0.00% 255,426 $0.10 $0.10 $0.10
    19 Jun 2024 $0.10 $0.00 0.00% 5,013 $0.10 $0.10 $0.10
    18 Jun 2024 $0.10 $0.00 0.00% 14,000 $0.10 $0.10 $0.10

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 May 2024 Jenelle Frewen Buy 190,740 $25,944
    On-market trade.
    28 May 2024 Robert Iervasi Buy 280,250 $24,795
    On-market trade.
    29 Apr 2024 Guy Headley Sell 3,500,000 $385,000
    On-market trade.
    23 Apr 2024 Guy Headley Sell 10,000,000 $1,100,000
    On-market trade.
    15 Dec 2023 Rodney Cocks Issued 1,241,808 $335,288
    Issue of securities.
    30 Aug 2023 Guy Headley Expiry 1,500,000 $577,500
    Options expired.
    25 Aug 2023 Guy Headley Buy 1,500,000 $405,000
    Exercise of options.
    25 Aug 2023 Guy Headley Exercise 1,500,000 $405,000
    Exercise of options.
    21 Jul 2023 Guy Headley Expiry 1,500,000 $750,000
    Options expired. As per announcement on 28-07-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Guy Rothwell Headley Non-Executive Director Dec 2021
    Mr Headley has operated in the Australian Medicinal Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last seven years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chairman of the Emerging Therapeutics Association of Australia.
    Ms Marcia Ani Matekino Walker Non-Executive Director Dec 2021
    Ms Walker brings experience in Medical Governance and formerly served on the board of the New Zealand Medical Association and as a member of the General Practitioner Council of the NZMA, a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association.
    Ms Jenelle Lee Frewen Non-Executive Director Sep 2022
    Ms Frewen is an accomplished government strategist and adviser with more than two decades' experience spanning complex policy development and implementation in regulated industries. She has led several federal and state political campaigns, and advised a range of business clients on public affairs and regulatory policy. She has experience working at all three levels of government in Australia and in new areas of policy-making in technology, broadband and cyber safety. Jenelle also spent time in her early career working as a communications and media adviser in the private sector in Australia, and was a senior aide in municipal government in the United States. She is currently Principal Consultant with the Canberra-based advisory firm, Precision Public Affairs.
    Mr Robert Iervasi Non-Executive ChairmanNon-Executive Director Feb 2024
    Mr Iervasi is a Chair, Board Director, former Group CEO, CFO and General Counsel. Most recently he was the Group CEO of Asahi Beverages, which owns Carlton and United Breweries (CUB). Currently, Mr Iervasi serves as Chair at Luv a Duck and Charters Paper, and is a Non Executive Director at SPC Global. With a background in both corporate governance and consumer products, Mr Iervasi is experience as a CFO, General Counsel and CEO through the various executive and Board roles he has held, including Asahi Beverages, HS Fresh Foods Group, Allpress Expresso and Circular Plastics Australia.
    Mr Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO Aug 2020
    -
    Guy R. Headley Chief Commercial Officer
    -
    Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO
    -
    Jessimine C.K. Jansen Chief Operating Officer
    -
    Ryan J. Tattle Chief Revenue Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Elizabeth Sarah Jansen <Stanford Investment Trust> 118,957,765 21.30%
    Guy Rothwell Headley 109,048,772 19.53%
    Cronos Global Holdings Inc. 55,176,065 9.88%
    Matua Hasyo Charlie Jansen <Whanau Family Trust> 47,738,638 8.55%
    HSBC Custody Nominees (Australia) Limited 22,470,003 4.02%
    NewSouthern Investment Holdings 1 Pty. Ltd.<NewSouthern Investment Trust 1> 21,000,000 3.76%
    NewSouthern Investment Holdings A Pty. Ltd. 20,000,000 3.58%
    Stone Group Pty. Ltd. <Stone Children A/C> 19,950,243 3.57%
    Ashanna Pty. Ltd. 10,766,897 1.93%
    Hektares SG Holdings Pte. Ltd. 6,665,216 1.19%
    UBS Nominees Pty. Ltd. 5,974,530 1.07%
    Citicorp Nominees Pty. Limited 4,958,589 0.89%
    Jessimine Jansen 4,653,379 0.83%
    BNP Paribas Nominees Pty. Ltd. <IB AU Noms Retail Client DRP> 4,266,870 0.76%
    Daniel Francis Birch <BES A/C> 3,798,013 0.68%
    Ryan Tattle 3,451,189 0.62%
    Arawhero Pty. Ltd. <Arawhero Super Fund A/C> 2,975,604 0.53%
    Kanmed Investments Pty. Ltd. 2,368,718 0.42%
    Marienburg Pty. Ltd. <Robinson Family A/C> 1,779,160 0.32%
    BG & Dewar Pty. Ltd. 1,373,500 0.25%

    Profile

    since

    Note